These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2775849)
1. Aggregation of amphotericin B in the presence of gamma-cyclodextrin. Kajtár M; Vikmon M; Morlin E; Szejtli J Biopolymers; 1989 Sep; 28(9):1585-96. PubMed ID: 2775849 [TBL] [Abstract][Full Text] [Related]
2. Solubilization of amphotericin B with gamma-cyclodextrin. Vikmon M; Stadler-Szöke A; Szejtli J J Antibiot (Tokyo); 1985 Dec; 38(12):1822-4. PubMed ID: 4093341 [No Abstract] [Full Text] [Related]
3. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp. Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510 [TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B. Jansook P; Pichayakorn W; Muankaew C; Loftsson T Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786 [TBL] [Abstract][Full Text] [Related]
5. A novel formulation of solubilised amphotericin B designed for ophthalmic use. Serrano DR; Ruiz-Saldaña HK; Molero G; Ballesteros MP; Torrado JJ Int J Pharm; 2012 Nov; 437(1-2):80-2. PubMed ID: 22890190 [TBL] [Abstract][Full Text] [Related]
6. Increasing the solubility characteristics of griseofulvin with gamma-cyclodextrin. Kata M; Tüske B Pharmazie; 1988 Jan; 43(1):52-3. PubMed ID: 3375309 [No Abstract] [Full Text] [Related]
7. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV. Hegge AB; Másson M; Kristensen S; Tønnesen HH Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675 [TBL] [Abstract][Full Text] [Related]
8. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate. Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427 [TBL] [Abstract][Full Text] [Related]
10. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin]. Chen JY; Tsai WY Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826 [TBL] [Abstract][Full Text] [Related]
11. Circular dichroism studies on intermolecular interactions of amphotericin B in ionic liquid-rich environments. Jameson LP; Dzyuba SV Chirality; 2013 Jul; 25(7):427-32. PubMed ID: 23695916 [TBL] [Abstract][Full Text] [Related]
12. Cyclodextrins in drug carrier systems. Uekama K; Otagiri M Crit Rev Ther Drug Carrier Syst; 1987; 3(1):1-40. PubMed ID: 3542243 [TBL] [Abstract][Full Text] [Related]
13. Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases. Uekama K; Hirayama F; Fujise A; Otagiri M; Inaba K; Saitô H J Pharm Sci; 1984 Mar; 73(3):382-4. PubMed ID: 6585547 [TBL] [Abstract][Full Text] [Related]
14. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state. Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623 [No Abstract] [Full Text] [Related]
15. The potential use of cyclodextrins in parenteral formulations. Brewster ME; Simpkins JW; Hora MS; Stern WC; Bodor N J Parenter Sci Technol; 1989; 43(5):231-40. PubMed ID: 2681643 [TBL] [Abstract][Full Text] [Related]
16. A Theoretical Analysis of Interaction Energies and Intermolecular Interactions between Amphotericin B and Potential Bioconjugates Used in the Modification of Nanocarriers for Drug Delivery. Cuellar J; Parada-Díaz L; Garza J; Mejía SM Molecules; 2023 Mar; 28(6):. PubMed ID: 36985646 [TBL] [Abstract][Full Text] [Related]
17. Improvement in the percutaneous absorption of beclomethasone dipropionate by gamma-cyclodextrin complexation. Uekama K; Otagiri M; Sakai A; Irie T; Matsuo N; Matsuoka Y J Pharm Pharmacol; 1985 Aug; 37(8):532-5. PubMed ID: 2864411 [TBL] [Abstract][Full Text] [Related]
18. Inclusion complexes of cyclodextrins with organic drug molecules. Uekama K Jpn J Antibiot; 1979 Dec; 32 Suppl():S103-11. PubMed ID: 398896 [No Abstract] [Full Text] [Related]
19. Molecular insight into the inclusion of the dietary plant flavonol fisetin and its chromophore within a chemically modified γ-cyclodextrin: Multi-spectroscopic, molecular docking and solubility studies. Pahari B; Chakraborty S; Sengupta PK Food Chem; 2018 Sep; 260():221-230. PubMed ID: 29699666 [TBL] [Abstract][Full Text] [Related]
20. Use of cyclodextrins in isotachophoresis. VI. Cyclodextrins as leading electrolyte additives for the separation of bile acids. Snopek J; Smolková-Keulemansová E; Jelínek I; Dohnal J; Klinot J; Klinotová E J Chromatogr; 1988 Oct; 450(3):373-9. PubMed ID: 3241020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]